Lesion Clinical Trials

215 recruitingLast updated: May 13, 2026

There are 215 actively recruiting lesion clinical trials across 47 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Lesion Trials at a Glance

215 actively recruiting trials for lesion are listed on ClinicalTrialsFinder across 6 cities in 47 countries. The largest study group is Not Applicable with 105 trials, with the heaviest enrollment activity in New York, Houston, and Boston. Lead sponsors running lesion studies include M.D. Anderson Cancer Center, Peking University Third Hospital, and Aura Biosciences.

Treatments under study

About Lesion Clinical Trials

Looking for clinical trials for Lesion? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lesion trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lesion clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 215 trials

Recruiting
Phase 2

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

HPV InfectionASC-USUterine Cervical Dysplasia+3 more
Amplexd Therapeutics, Inc.45 enrolled1 locationNCT07572396
Recruiting
Not Applicable

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation1,616 enrolled50 locationsNCT06959524
Recruiting
Not Applicable

A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors

Brain TumorBrain CancerMotor Cortex; Lesion
Medical College of Wisconsin20 enrolled1 locationNCT05023434
Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Smoldering Multiple MyelomaMyelodysplastic SyndromesWaldenstrom Macroglobulinemia+5 more
Dana-Farber Cancer Institute10,000 enrolled7 locationsNCT02269592
Recruiting

Top-Down Attentional Control of Visual-Processing

fMRIFocal Brain LesionFocal Lesions
National Institute of Mental Health (NIMH)300 enrolled1 locationNCT01087281
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi84 enrolled69 locationsNCT06500702
Recruiting
Not Applicable

Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis

Anal CancerSquamous Cell CarcinomaSquamous Intraepithelial Lesions+3 more
Universitair Ziekenhuis Brussel296 enrolled8 locationsNCT07029152
Recruiting
Not Applicable

Air-polishing With Erythritol During Orthodontic Tretament

Inflammation GumWhite Spot Lesion
Catherine Giannopoulou60 enrolled1 locationNCT05989750
Recruiting

Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis

Gastric CarcinomaIntestinal MetaplasiaGastritis Chronic+1 more
Yongquan Shi450 enrolled1 locationNCT07542652
Recruiting
Not Applicable

Photobiomodulation, Photodynamic Therapy, and Clobetasol in the Treatment of Oral Lichen Planus.

Oral Lichen PlanusErosive Lichen PlanusMucosal Lesions
Medical University of Silesia60 enrolled1 locationNCT07278999
Recruiting
Not Applicable

Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy

Chondral Lesion of the KneeCartilage Defects of the KneeOsteoarthritis(OA) of the knee+1 more
Hospital for Special Surgery, New York50 enrolled1 locationNCT06893302
Recruiting
Not Applicable

Effect of PRP Injection on Voice Recovery After Benign Vocal Fold Surgery

Benign Vocal Fold Lesions
Beni-Suef University64 enrolled1 locationNCT07300800
Recruiting

A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions

Mucosal Lesionskin lesion
Memorial Sloan Kettering Cancer Center5,010 enrolled1 locationNCT04743362
Recruiting

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Soft Tissue Lesion
Galvanize Therapeutics, Inc.1,000 enrolled10 locationsNCT05851430
Recruiting
Not Applicable

Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery

pressure injurySkin injurySkin Lesions
Istanbul Medipol University Hospital90 enrolled1 locationNCT07523958
Recruiting
Not Applicable

Evaluation of the Osteointegrative and Regenerative Capacity of a Scaffold Enriched With Bone Marrow-Derived Cells at the Subchondral Level, Associated With Retrograde Drilling

Osteochondral Lesion
Istituto Ortopedico Rizzoli20 enrolled1 locationNCT07555899
Recruiting
Not Applicable

Laser Treatment for Lichen Sclerosus

Lichen Sclerosus Lesion
Sciton50 enrolled1 locationNCT06389071
Recruiting
Not Applicable

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

Knee Cartilage Lesions
Nanochon, Inc.10 enrolled2 locationsNCT07249489
Recruiting
Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions

For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions
Shanghai Shengdi Pharmaceutical Co., Ltd250 enrolled2 locationsNCT07275814
Recruiting

Post-Debonding Finishing in Orthodontics

CariesEnamel Lesions
University of Roma La Sapienza100 enrolled1 locationNCT07534423